peripheral arterial occlusive disease / bloodletting

And what exactly are we to make of this, how does it relate
to any body of theory, to what practical use is it, and to
what goal can it be useful? Without this information it is
but another random abstract plucked from the web, one among
thousands of such.

Quoted message said:

Subject: Re: peripheral arterial occlusive disease / bloodletting

Schweiz Med Wochenschr. 1989 Dec 23;119(51):1862-7. Related
Articles, Links

[Hemodilution in patients with multiple morbidity and
peripheral arterial occlusive disease]

[Article in German]

Kiesewetter H, Blume J, Jung F, Spitzer S, Bach R, Birk A,
Schieffer H, Wenzel
E.

Abteilung fur Klinische Hamostaseologie und
Transfusionsmedizin Universitat des Saarlandes, Homburg-
Saar, BRD.

The treatment of multi-morbid patients suffering from
peripheral arterial occlusive disease (PAOD) is rendered
difficult due to concomitant diseases such as coronary heart
disease, chronic obstructive pulmonary affection, arterial
hypertension or diabetes mellitus. Haemodilution can be a
clinically efficient therapy for some of the concomitant
diseases as well. It is, however, necessary to use a weak
colloidal solution which has no additional volume effect as
an iso-oncotic substance. Hydroxyethyl starch 200/0.5 6%
meets all these demands. In a double-blind, placebo-
controlled study over a period of 6 weeks a marked and
significant increase of almost 40% in painfree walking
distance was achieved for 19 of 37 multi-morbid patients
with PAOD II by moderate hypervolaemic haemodilution with
venesections. Besides the clinical improvement, blood
fluidity also increased through a reduction in haematocrit,
plasma viscosity, and erythrocyte aggregation.

Publication Types: Clinical Trial Controlled Clinical Trial
Randomized Controlled Trial

PMID: 2481883 [PubMed - indexed for MEDLINE]

------------------------------------------------------------
--------------
------

Who loves ya. Tom Jesus Was A Vegetarian!
jesuswasavegetarian.7h.comjesuswasavegetarian.7h.comOpen ↗ Man Is A Herbivore!
pages.ivillage.commanisaherbivoreOpen ↗ DEAD
PEOPLE WALKING
pages.ivillage.comdeadpeoplewalkingOpen ↗

(X 2)

And what exactly are we to make of this, how does it relate
to any body of theory, to what practical use is it, and to
what goal can it be useful? Without this information it is
but another random abstract plucked from the web, one among
thousands of such.

Quoted message said:

Subject: Re: peripheral arterial occlusive disease / bloodletting

Quoted message said:

And what exactly are we to make of this, how does it relate
to any body of theory, to what practical use is it, and to
what goal can it be useful? Without this information it is
but another random abstract plucked from the web, one among
thousands of such.

It is called .. bloodletting ..

Bloodletting .. is .. good ..

Schweiz Med Wochenschr. 1989 Dec 23;119(51):1862-7. Related
Articles, Links

[Hemodilution in patients with multiple morbidity and
peripheral arterial occlusive disease]

[Article in German]

Kiesewetter H, Blume J, Jung F, Spitzer S, Bach R, Birk A,
Schieffer H, Wenzel
E.

Abteilung fur Klinische Hamostaseologie und
Transfusionsmedizin Universitat des Saarlandes, Homburg-
Saar, BRD.

The treatment of multi-morbid patients suffering from
peripheral arterial occlusive disease (PAOD) is rendered
difficult due to concomitant diseases such as coronary heart
disease, chronic obstructive pulmonary affection, arterial
hypertension or diabetes mellitus. Haemodilution can be a
clinically efficient therapy for some of the concomitant
diseases as well. It is, however, necessary to use a weak
colloidal solution which has no additional volume effect as
an iso-oncotic substance. Hydroxyethyl starch 200/0.5 6%
meets all these demands. In a double-blind, placebo-
controlled study over a period of 6 weeks a marked and
significant increase of almost 40% in painfree walking
distance was achieved for 19 of 37 multi-morbid patients
with PAOD II by moderate hypervolaemic haemodilution with
venesections. Besides the clinical improvement, blood
fluidity also increased through a reduction in haematocrit,
plasma viscosity, and erythrocyte aggregation.

Publication Types: Clinical Trial Controlled Clinical Trial
Randomized Controlled Trial

PMID: 2481883 [PubMed - indexed for MEDLINE]

------------------------------------------------------------
--------------
------

Who loves ya. Tom Jesus Was A Vegetarian!
jesuswasavegetarian.7h.comjesuswasavegetarian.7h.comOpen ↗ Man Is A Herbivore!
pages.ivillage.commanisaherbivoreOpen ↗ DEAD
PEOPLE WALKING
pages.ivillage.comdeadpeoplewalkingOpen ↗